Location History:
- Appleton Thorn, GB (2022)
- Warrington, GB (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: June Gladman: A Pioneer in Chitosan Innovations
Introduction
June Gladman is a notable inventor based in Warrington, GB, recognized for her significant contributions to the field of chitosan technology. With a remarkable portfolio of 11 patents, she has emerged as a key figure in developing processes that enhance the properties and usability of chitosan, a biopolymer derived from chitin.
Latest Patents
Among her latest innovations, June has developed a patented process for producing low endotoxin chitosan. This process involves contacting chitosan, chitin, or their derivatives with an alkali solution, resulting in a low endotoxin alkali chitosan that can be utilized in various applications. The procedure includes mixing the components and leaving them for less than one hour, along with an option for drying the final mixture. Another patent mirrors this process, detailing the use of an alkali solution with a concentration of less than 0.25M, highlighting her commitment to optimizing production methods for chitosan derivatives.
Career Highlights
Throughout her career, June has made substantial contributions while working at Medtrade Products Limited and Convatec Technologies, Inc. Her innovative methods have not only advanced her career but have also opened doors for further research and application of chitosan-based products in various industries, particularly in biomedical and pharmaceutical fields.
Collaborations
In her journey, June has collaborated with professionals like Craig Julian Hardy and Andrew Hoggarth, fostering a creative and productive environment that has led to the development of groundbreaking patents. These collaborations have played a crucial role in refining her inventions and enhancing their practical applications.
Conclusion
June Gladman's work exemplifies the intersection of innovation and practical application in the field of biopolymers. Her patents, particularly surrounding low endotoxin chitosan, underscore her impact on enhancing product viability and usefulness in real-world applications. As she continues to push the boundaries of chitosan technology, there is no doubt that her future endeavors will further contribute to the scientific and medical communities.